These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2208759)

  • 1. Cardiovascular risk factors: multiple interventions in man.
    Schoenberger JA
    Clin Exp Hypertens A; 1990; 12(5):931-8. PubMed ID: 2208759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes of the decrease in cardiovascular mortality.
    Levy RI
    Am J Cardiol; 1984 Aug; 54(5):7C-13C. PubMed ID: 6475765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factor modification trials: implications for the elderly.
    Stamler J
    Eur Heart J; 1988 Mar; 9 Suppl D():9-53. PubMed ID: 3288476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why are death rates from coronary heart disease decreasing? Which preventive measures are effective?
    Watkins LO
    Postgrad Med; 1984 Jun; 75(8):201-8, 211, 214. PubMed ID: 6610175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet and the prevention of cardiovascular diseases.
    Paradis G; Fodor JG
    Can J Cardiol; 1999 Dec; 15 Suppl G():81G-8G. PubMed ID: 10692664
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple risk factor interventions for primary prevention of coronary heart disease.
    Ebrahim S; Davey Smith G
    Cochrane Database Syst Rev; 2000; (2):CD001561. PubMed ID: 10796813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials.
    Cutler JA; Neaton JD; Hulley SB; Kuller L; Paul O; Stamler J
    Prev Med; 1985 May; 14(3):293-311. PubMed ID: 3903734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of smoking combined with another risk factor on the risk of mortality from coronary heart disease and stroke: pooled analysis of 10 Japanese cohort studies.
    Nakamura K; Nakagawa H; Sakurai M; Murakami Y; Irie F; Fujiyoshi A; Okamura T; Miura K; Ueshima H;
    Cerebrovasc Dis; 2012; 33(5):480-91. PubMed ID: 22517421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in the Stockholm heart disease secondary prevention study.
    Werkö L
    J Intern Med; 1989 Jun; 225(6):427-8. PubMed ID: 2664065
    [No Abstract]   [Full Text] [Related]  

  • 10. How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects.
    Yudkin JS
    BMJ; 1993 May; 306(6888):1313-8. PubMed ID: 8518573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ["Under pressure" -- the clinical relevance of hypertension for the heart and circulation].
    Lüscher TF
    Herz; 2006 Jun; 31(4):285-6. PubMed ID: 16810467
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary and secondary prevention of cardiovascular disease in the elderly.
    García-Palmieri MR
    Bol Asoc Med P R; 2000; 92(1-3):3-8. PubMed ID: 10846280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The drug treatment of mild hypertension in the Multiple Risk Factor Intervention Trial. A review.
    Grimm RH
    Drugs; 1986; 31 Suppl 1():13-21. PubMed ID: 3720569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise in the reduction of cardiovascular events. Lessons from epidemiologic trials.
    Gibbons LW; Clark SM
    Cardiol Clin; 2001 Aug; 19(3):347-55. PubMed ID: 11570109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of lipid disorders in the elderly.
    Playford DA; Watts GF
    Drugs Aging; 1997 Jun; 10(6):444-62. PubMed ID: 9205850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipids and hypertension. Implications of new guidelines for cholesterol management in the treatment of hypertension.
    Grimm RH; Hunninghake DB
    Am J Med; 1986 Feb; 80(2A):56-63. PubMed ID: 3946462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention.
    Cooper R; Cutler J; Desvigne-Nickens P; Fortmann SP; Friedman L; Havlik R; Hogelin G; Marler J; McGovern P; Morosco G; Mosca L; Pearson T; Stamler J; Stryer D; Thom T
    Circulation; 2000 Dec; 102(25):3137-47. PubMed ID: 11120707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multiple risk factor intervention trial (MRFIT): implications for nurses.
    Ackerman AM; Froman D; Becker DM
    Prog Cardiovasc Nurs; 1987; 2(3):92-9. PubMed ID: 3313379
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular risk groups and mortality in an urban swedish male population: the Malmö Preventive Project.
    Berglund G; Eriksson KF; Israelsson B; Kjellström T; Lindgärde F; Mattiasson I; Nilsson JA; Stavenow L
    J Intern Med; 1996 Jun; 239(6):489-97. PubMed ID: 8656142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.